Citation Impact
Citing Papers
A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101
2012
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
2002 StandoutScienceNobel
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Polycomb Group Protein Enhancer of Zeste 2 Is an Oncogene That Promotes the Neoplastic Transformation of a Benign Prostatic Epithelial Cell Line
2009
Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)
2010
Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation
2002 StandoutNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
1993
Epidemiology and causes of preterm birth
2008 Standout
The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis
2007
Linking class-switch recombination with somatic hypermutation
2001 StandoutNobel
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
The creation of diversity in the human immunoglobulin Vλ repertoire
1997
Chemotherapy-induced neuropathy: A comprehensive survey
2014
MYC on the Path to Cancer
2012 Standout
The Systemic Amyloidoses
1997 Standout
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
2008 StandoutNature
Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR
2002 Standout
The Igκ 3′ Enhancer Influences the Ratio of Igκ versus Igλ B Lymphocytes
1996
Dominance of intrinsic genetic factors in shaping the human immunoglobulin Vλ repertoire
1999 StandoutNobel
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Developments in Quantitative PCR
1998
AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies
2008
A new mathematical model for relative quantification in real-time RT-PCR
2001 Standout
An AP1 binding site upstream of the kappa immunoglobulin intron enhancer binds inducible factors and contributes to expression
1994
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone
2010
The use of high‐dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome
2006
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
2011
, a Winged Helix Transcriptional Repressor with Expression Restricted to Embryonic Stem Cells
1996
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Putting tumours in context
2001 Standout
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
2009
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
1995 StandoutNatureNobel
Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells.
1997
Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4
1998 Standout
Genetic events in the pathogenesis of multiple myeloma
2007
Angiogenesis in B Cell Lymphoproliferative Diseases. Biological and Clinical Studies
1995
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
2007
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
2008
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Clonal selection and learning in the antibody system
1996 StandoutNature
Multiple myeloma: evolving genetic events and host interactions
2002
The PU.1 and NF-EM5 binding motifs in the Igκ 3′ enhancer are responsible for directing somatic hypermutations to the intrinsic hotspots in the transgenic Vκ gene
2001
Novel targeted deregulation of c-Myc cooperates with Bcl-XL to cause plasma cell neoplasms in mice
2004
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Mechanisms of Bone Metastasis
2004 Standout
Elements regulating somatic hypermutation of an immunoglobulin κ gene: Critical role for the intron enhancer/matrix attachment region
1994 Nobel
Molecular Principles of Oct2-Mediated Gene Activation in B Cells
1995
Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
2011
The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
1994 Standout
The occurrence and significance of V gene mutations in B cell—Derived human malignancy
2001
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme
2000 StandoutNobel
The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells
2003 StandoutNobel
Molecular Mechanisms of Amyloidosis
2003 Standout
The Polycomb complex PRC2 and its mark in life
2011 StandoutNature
Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA‐1, VLA‐4, LAM‐1, and CD44
1995
Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation
2001 StandoutNobel
Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation
1993
AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements
2007 StandoutNobel
Essential role of STAT3 for embryonic stem cell pluripotency
1999
B-Cell Control Region at the 5′ End of a Major Histocompatibility Complex Class II Gene: Sequences and Factors
1988
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
In vitro binding of cell-specific and ubiquitous nuclear proteins to the octamer motif of the SV40 enhancer and related motifs present in other promoters and enhancers.
1987
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
A hallmark of active class switch recombination: Transcripts directed by I promoters on looped-out circular DNAs
2001 StandoutNobel
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis
1995 StandoutScience
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
2001 Standout
Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma
2005
Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation
2011 StandoutNobel
Positive and Negative Regulation of V(D)J Recombination by the E2A Proteins
1999
Clonal Deletion Versus Clonal Anergy: The Role of the Thymus in Inducing Self Tolerance
1990 StandoutScienceNobel
The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
2008
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
2011 StandoutScience
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma
1995
ACCESSIBILITY CONTROL OF ANTIGEN-RECEPTOR VARIABLE-REGION GENE ASSEMBLY: Role ofcis-Acting Elements
1996
The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig VL germ line gene use and clonal plasma cell burden
2001
The molecular classification of multiple myeloma
2006
Oct2 Transactivation from a Remote Enhancer Position Requires a B-Cell-Restricted Activity
1992
A novel membrane antigen selectively expressed on terminally differentiated human B cells
1994
Genetics and Cytogenetics of Multiple Myeloma
2004
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
2009
Histone Acetylation Determines the Developmentally Regulated Accessibility for T Cell Receptor γ Gene Recombination
2001 StandoutNobel
Use and Abuse of RNAi to Study Mammalian Gene Function
2012 StandoutScienceNobel
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Ordered rearrangement of variable region genes of the T cell receptor gamma locus correlates with transcription of the unrearranged genes.
1993
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Multiple Myeloma
2011 Standout
High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients
1993
Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma
1999
Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation.
1996
Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.
1996 StandoutNobel
Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.
1994 Nobel
Sequential Induction of NF-κB/Rel Family Proteins during B-Cell Terminal Differentiation
1994 Nobel
Primary Myeloma Cells Growing in SCID-hu Mice: A Model for Studying the Biology and Treatment of Myeloma and Its Manifestations
1998
Increased Tumor Proliferation and Genomic Instability without Decreased Apoptosis in MMTV-ras Mice Deficient in p53
1997
Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma
1999
Works of Brian Van Ness being referenced
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
2002
The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro
2001
Developmental Regulation of the κ Locus Involves Both Positive and Negative Sequence Elements in the 3′ Enhancer That Affect Synergy with the Intron Enhancer
1999
Quantitation of T‐cell receptor Vβ chain expression on lymphocytes from blood, brain, and spinal fluid in patients with multiple sclerosis and other neurological diseases
1992
Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells
2002
Effects of anti-IgM suppression on polyclonally activated murine B cells: analysis of immunoglobulin mRNA, gene specific nuclear factors and cell cycle distribution
1989
Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions
1993
The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype
2005
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma
1996
Identification of an Octamer-Binding Site in the Human Kappa Light-Chain Enhancer
1990
Nuclear factors bind to regulatory regions of the mouse kappa immunoglobulin gene
1986
Clinical and biologic implications of recurrent genomic aberrations in myeloma
2003
Induced rearrangement of kappa genes in the BLIN-1 human pre-B cell line correlates with germline J-C kappa and V kappa transcription.
1991
Identification of an octamer-binding site in the human kappa light-chain enhancer.
1990
Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease
1991
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients
1992
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial
1996
Inducible DNA-protein interactions of the murine kappa immunoglobulin enhancer in intact cells: comparison within vitrointeractions
1988
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma
1996
Plasmablastic Morphology—An Independent Prognostic Factor With Clinical and Laboratory Correlates: Eastern Cooperative Oncology Group (ECOG) Myeloma Trial E9486 Report by the ECOG Myeloma Laboratory Group
1998
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients
2002
Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies
2003
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy
2001
Circulating Blood B Cells in Multiple Myeloma: Analysis and Relationship to Circulating Clonal Cells and Clinical Parameters in a Cohort of Patients Entered on the Eastern Cooperative Oncology Group Phase III E9486 Clinical Trial
1997
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients
1992
Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
2011
Novel targeted deregulation of c-Myc cooperates with Bcl-XL to cause plasma cell neoplasms in mice
2004
Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.
1995
Is Flow Cytometric DNA Content Hypodiploidy Prognostic in Multiple Myeloma?
1999
The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
1993
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications
2006